FDA Drug recall D-0833-2016
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc
- FDA Drug
- Class III
- terminated
- Published 2016-04-27
On 2016-04-27 the FDA classified a Class III recall of Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc by Abbvie, citing failed Content Uniformity Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0833-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-03-24 |
| Published | 2016-04-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Abbvie |
| Distribution | US |
Product
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.
Reason
Failed Content Uniformity Specifications
Identifiers
| ndc | 0074-4314-30 |
|---|---|
| ndc | 0074-4317-30 |
| ndc | 0074-4317-73 |
| ndc | 0074-9036-30 |
| ndc | 0074-9037-30 |
| code_info | Lot #1055586, Exp.1/21/ 2018 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0833-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.